MONTREAL, CANADA — Lallemand announced the completion of an equity investment in Livzym Biotechnologies through its Swiss affiliate Danstar Ferment AG as part of a strategic collaboration.
“We are committed to making biotechnology one of the answers to the challenges the world faces with respect to nutrition, health and the environment,” said Lars Asferg, president of Lallemand Bio-Ingredients. “Lallemand is a major global producer of yeast and entered the baking enzyme market in 2019 with our proprietary LallZyme range based on our yeast technology. We have since expanded our enzyme presence with acquisitions of the BASF Nutrilife food and Spartec bio-fuel enzymes businesses. The strategic collaboration with Livzym and their fungal development and production platform perfectly complements our position within the enzymes sector. The Inclusion of Livzym’s enzymes within Lallemand’s portfolio will enable us to provide our customers with an exciting range of high-performance enzymes.”